Assistant Professor in General Internal Medicine, Aaron Scherer, PhD, is the primary investigator (PI) for a large, cooperative agreement with the Centers for Disease Control and Prevention (CDC) to conduct surveys on immunization-related issues with health care professionals and the general public. His and his team’s work help inform the CDC’s Advisory Committee on Immunization […]
Lessons from an ongoing pandemic
The beginning of June represents the home stretch for the academic year. This month will be filled with a number of transitions, most notably our residency and fellowship graduations. At the end of this month we will begin the welcoming and onboarding of a new class of interns and more than a few new faculty […]
23rd Annual Update in Infectious Diseases, 4/22/2022
Three years have passed since the last in-person version of this Continuing Medical Education conference hosted by the Division of Infectious Diseases. That year, 2019, a different pandemic took center stage in the programming as the division celebrated the 30-year anniversary of the founding of the HIV/AIDS Clinic at UI Health Care. It can be […]
Dayal, Lentz receive R01 to investigate COVID-19 clotting
Sanjana Dayal, PhD, and Steven Lentz, MD, PhD, received a $3.36M R01 grant from the National Institute of Allergy and Infectious Diseases. The grant, titled “Cellular Effects of SARS-CoV-2 in Mediating Thrombotic Susceptibility,” will allow Dayal and Lentz to investigate whether an increase in cytokines as a result of COVID-19 can activate blood cells and […]
Kline’s media campaign for vaccinating pregnant women
Many of our faculty and staff in the department and at University of Iowa Health Care have been quick to add another role, public advocate, to their educator-researcher-clinician roles over the course of the pandemic. We have always responded to requests for interviews, serving as experts on everything from updated colonoscopy screening guidelines to the […]
Timely and tragic case report examines COVID-19 vaccine for the immunocompromised
After SARS-CoV-2 began to rapidly spread across the globe in 2020, there was a rush to develop safe and effective vaccines that could slow the spread and limit the severity of the virus. Although the mRNA vaccines reduce symptoms of COVID-19 by more than 90%, the efficacy of these mRNA vaccines in immunocompromised people has […]
Perepu, Chambers lead trial of proper dosage for COVID-19 thrombosis
Thrombosis is commonly associated with COVID-19; however, the impact of enoxaparin, an anti-clotting drug, on COVID-19 remains uncertain. Usha Perepu, MBBS, MRCP, clinical associate professor in Hematology, Oncology, and Blood and Marrow Transplantation, and Isaac Chambers, MD, former Hematology and Medical Oncology chief fellow, conducted a multi-center, open-label, randomized, controlled trial comparing the outcome of […]
Carvour launches health equity projects with P3 funds
Martha Carvour, MD, PhD, has received a three-year, $758K grant from the University of Iowa’s Strategic Initiatives Fund (UISIF) to begin a series of campus- and community-wide projects aimed at improving equity in health science and practice (E-HSP). Funds in the UISIF are generated from the public-private partnership Iowa established in 2019 and are to […]
Protecting Iowa’s vulnerable farmworkers expands to include vaccinations
While COVID-19 vaccinations are well underway in Iowa, Claudia Corwin, MD, MPH, assistant professor in Pulmonary, Critical Care and Occupational Medicine, and associate medical director of University of Iowa Health Care’s Employee Health Clinic, has been working to help ensure one critical sector of the population is not overlooked — Iowa’s migrant and seasonal agricultural […]
Dayal to examine COVID-19 clotting
Sanjana Dayal, PhD, assistant professor in Hematology, Oncology and Blood & Marrow Transplantation, received a $50,000 COVID-19 Pilot Grant from the Roy J. Carver Charitable Trust. This funding will allow Dayal to examine the mechanisms of hypercoagulation in COVID-19 mouse models. Hypercoagulation, also known as excessive blood clotting, tends to occur in COVID-19 patients and often […]